Pharmix Corporation
5Patents
0Active
5Granted
26Portfolio score
Filing activity: Mar 10, 2000 → Jun 29, 2005
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7194359B2 | Estimating the accuracy of molecular property models and predictions | Physics | 12 | Expired |
| US6571226B1 | Method and apparatus for automated design of chemical synthesis routes | Chemistry; Metallurgy | 12 | Expired |
| US7183285B2 | Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase | Emerging Cross-Sectional Technologies | 2 | Expired |
| US7163945B2 | Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase | Human Necessities | 0 | Expired |
| US7199126B2 | Compositions and treatments for inhibiting kinase and/or HMG-CoA reductase | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.